Literature DB >> 3612497

Caffeine and paraxanthine pharmacokinetics in the rabbit: concentration and product inhibition effects.

S H Dorrbecker, R A Ferraina, B R Dorrbecker, P A Kramer.   

Abstract

The disposition of caffeine (C) and its major metabolite paraxanthine (P) have been determined following i.v. bolus dosing both separately and concomitantly to New Zealand White rabbits. Caffeine clearances of 1.52-6.71 ml/min/kg were observed and were suggestive of polymorphism with rapid (type I) and slow (type II) metabolizing subpopulations represented. Type II metabolizers exhibited dose-independent pharmacokinetics for C, while the clearances of type I animals were dose-dependent (lower clearances at higher doses). The P clearances were not dose-dependent. In type I rabbits coadministration of P inhibited C metabolism by as much as 71%. Results were consistent with the hypothesis that at least two forms of cytochrome "P-450" mediate the metabolism of C in the rabbit.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3612497     DOI: 10.1007/bf01062339

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  13 in total

1.  Kinetics of caffeine metabolism in control and 3-methylcholanthrene induced rat liver microsomes.

Authors:  M Bonati; A Celardo; F Galletti; R Latini; F Tursi; G Belvedere
Journal:  Toxicol Lett       Date:  1984-04       Impact factor: 4.372

Review 2.  Physiological disposition of caffeine.

Authors:  A W Burg
Journal:  Drug Metab Rev       Date:  1975       Impact factor: 4.518

Review 3.  Multiple forms of cytochrome P-450 and the importance of molecular biology and evolution.

Authors:  D W Nebert; M Negishi
Journal:  Biochem Pharmacol       Date:  1982-07-15       Impact factor: 5.858

4.  Improved micro-method for the high-performance liquid chromatographic determination of caffeine and paraxanthine in biological fluids.

Authors:  B R Dorrbecker; S H Mercik; P A Kramer
Journal:  J Chromatogr       Date:  1984-12-12

5.  Caffeine disposition in the pregnant rabbit. I. Pharmacokinetics following administration by intravenous bolus and continuous zero-order infusion.

Authors:  S H Dorrbecker; J R Raye; B R Dorrbecker; P A Kramer
Journal:  Dev Pharmacol Ther       Date:  1988

6.  Studies on theobromine disposition in normal subjects. Alterations induced by dietary abstention from or exposure to methylxanthines.

Authors:  D D Drouillard; E S Vesell; B H Dvorchik
Journal:  Clin Pharmacol Ther       Date:  1978-03       Impact factor: 6.875

7.  Caffeine disposition after oral doses.

Authors:  M Bonati; R Latini; F Galletti; J F Young; G Tognoni; S Garattini
Journal:  Clin Pharmacol Ther       Date:  1982-07       Impact factor: 6.875

8.  Plasma and salivary pharmacokinetics of caffeine in man.

Authors:  R Newton; L J Broughton; M J Lind; P J Morrison; H J Rogers; I D Bradbrook
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine, in the rat.

Authors:  A Bortolotti; L Jiritano; M Bonati
Journal:  Drug Metab Dispos       Date:  1985 Mar-Apr       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.